TEVA -- Is Its Stock Price A Worthy Investment? Learn More.
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva stock drops on guidance, manufacturing problems - MarketWatch
Teva to lay off 14,000 workers in bid for survival — but some are skeptical - MarketWatch
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Drug maker Teva's U.S. unit indicted on price-fixing charges - MarketWatch
Teva Can Reach $100 on Allergan Unit Acquisition - Barron's
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Teva shares surge on corporate shake-up - MarketWatch
Teva lifts forecast as Q3 sales top estimates
Teva to lay off 14,000 workers in bid for survival — but some are skeptical - MarketWatch
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
TEVA Stock Price | Teva Pharmaceutical Industries Ltd. ADR Stock Quote (U.S.: NYSE) | MarketWatch
Drugmaker Teva Pharmaceuticals found guilty for contribution to opioid crisis - MarketWatch
Teva Reports Growth in Fourth Quarter and Full Year 2023
Teva shares hit 19-year low after opioid settlement, analyst downgrades | Fierce Pharma
Teva: Another Day, Another Downgrade - Barron's
Teva's Austedo, Ajovy sales offset Q4 declines in generics
Months after joining, Teva CEO pulls curtain back on strategy to return to growth
Is Teva A Falling Drug Company Or A Great Value Proposition (NYSE:TEVA) | Seeking Alpha
Teva to acquire Mexico's Rimsa for $2.3 billion - MarketWatch
Teva Pharmaceutical Is in Recovery - WSJ
Mylan sees opportunity in rival Teva's weakness - MarketWatch
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Billionaire health-care investor Phillip Frost charged by SEC with pump-and-dump schemes - MarketWatch
